Just – Evotec Signs a Development and Manufacturing Agreement with OncoResponse for OR2805

Shots:

• Just-Evotec to leverage its technology platform, J.Design to accelerate OncoResponse’s OR2805 through the development and into the clinic
• Just-Evotec provides services to the OncoResponse which includes cell line development, process development, and P-I/II cGMP clinical manufacturing of OR2805 in human clinical studies
• OncoResponse’s OR2805 is an Ab, reversing the immunosuppression in the tumor microenvironment and promoting cancer-killing, leading to higher response rates

Click here ­to­ read full press release/ article | Ref: Evotec | Image: Canaan